USPTO Grants Reissuance Of Lovenox Patent
The USPTO previously rejected two attempts to file an application to reissue the patent.
The drug maker said a new U.S. patent for Lovenox could be issued by mid-2005. During the reissuance process, the current patent remains in force but will be replaced by the new patent when it is issued. The...
To view the full article, register now.